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High density lipoprotein (HDL) can protect low den-
sity lipoprotein (LDL) against oxidation. Oxidized cho-
lesterol esters from LDL can be transferred to HDL and
efficiently and selectively removed from the blood cir-
culation by the liver and adrenal in vivo. In the present
study, we investigated whether scavenger receptor BI
(SR-BI) is responsible for this process. At 30 min after
injection, the selective uptake of oxidized cholesterol
esters from HDL for liver and adrenal was 2.3- and 2.6-
fold higher, respectively, than for native cholesterol es-
ters, whereas other tissues showed no significant differ-
ence. The selective uptake of oxidized cholesterol esters
from HDL by isolated liver parenchymal cells could be
blocked for 75% by oxidized LDL and for 50% by phos-
phatidylserine liposomes, both of which are known sub-
strates of SR-BI.
In vivo uptake of oxidized cholesterol esters from HDL
by parenchymal cells decreased by 64 and 81% when rats
were treated with estradiol and a high cholesterol diet,
respectively, whereas Kupffer cells showed 660 and
475% increases, respectively. These contrasting changes
in oxidized cholesterol ester uptake were accompanied
by similar contrasting changes in SR-BI expression of
parenchymal and Kupffer cells. The rates of SR-BI-me-
diated selective uptake of oxidized and native choles-
terol esters were analyzed in SR-BI-transfected Chinese
hamster ovary cells. SR-BI-mediated selective uptake
was 3.4-fold higher for oxidized than for native choles-
terol esters (30 min of incubation). It is concluded that in
addition to the selective uptake of native cholesterol
esters, SR-BI is responsible for the highly efficient se-
lective uptake of oxidized cholesterol esters from HDL
and thus forms an essential mediator in the HDL-asso-
ciated protection system for atherogenic oxidized cho-
lesterol esters.
High density lipoprotein (HDL)1 may exert its anti-athero-
genic effects by various mechanisms (1, 2). First, reverse cho-
lesterol transport, as originally proposed by Glomset (3), is a
widely accepted mechanism of anti-atherogenic action. In this
concept, HDL accepts excessive cholesterol from extrahepatic
cells for transport to the liver parenchymal cells (3, 4). The
direct uptake of native HDL cholesteryl ester (HDL-CE) by
liver parenchymal cells is fundamentally different from that of
the classical LDL receptor pathway in that HDL-CEs are taken
up selectively without simultaneous uptake of the holoparticle
(5, 6). This so-called selective uptake of HDL-CE in the liver
parenchymal cells is efficiently coupled to bile acid formation
and secretion (4). A second mechanism for the anti-atherogenic
action of HDL is related to its antioxidative properties (7).
Several mechanisms have been proposed by which HDL can
prevent oxidative damage of LDL. One of the possible mecha-
nisms that have been suggested involves the transfer of reac-
tive oxidized lipids from LDL to HDL and the subsequent
efficient transport to the liver for biliary secretion (2, 8, 9). The
rapid removal of the oxidized lipids may prevent the propaga-
tion of an oxidation cascade in LDL. Bowry et al. (10) showed
that HDL is the predominant carrier of cholesteryl ester hy-
droperoxides (CEOOH) in humans. The first step in LDL oxi-
dation involves hydroperoxide formation, and it is suggested
that HDL may accept CEOOH from LDL and that this process
is possibly mediated by cholesteryl ester transfer protein (11).
Moreover, a HDL-associated hydroperoxide-reducing activity
was found that converted the reactive CEOOH to the less
reactive cholesteryl ester hydroxides (CEOH) (9). Previous
studies (2) have shown that oxidized cholesterol esters are
taken up extremely efficiently as compared with native choles-
terol esters by the liver parenchymal cells and this uptake is
coupled to an increased rate of biliary secretion, indicating that
the efficient liver uptake indeed might lead to the irreversible
removal from serum of the reactive oxidized cholesterol esters
in vivo. The hypothesis was put forward that this antioxidant
mechanism may use the same selective uptake pathway as that
used during normal reverse cholesterol transport but with a
much higher efficiency (2).
Acton et al. (12) recently provided the first evidence that
scavenger receptor class BI (SR-BI), a member of the CD 36
family (13), binds HDL and can also mediate the selective
uptake of HDL-CE. SR-BI was found to bind a broad spectrum
of ligands, including both modified and native lipoproteins and
anionic phospholipids (14). The binding of HDL to SR-BI was
shown to be mediated by the major apolipoproteins of HDL, e.g.
apoA-I, apoA-II, and apoC-III (15). We showed recently that the
selective uptake of HDL-CE by isolated rat liver parenchymal
cells can be inhibited completely by ligands specific for SR-BI
(16), indicating that the expression of SR-BI can be solely
responsible for the selective HDL-CE uptake in this cell type.
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In vivo, SR-BI is expressed in the steroidogenic organs and
liver of rodents (12, 17, 18), which all display selective uptake
of HDL-CE. In the steroidogenic tissues, SR-BI expression is
coordinately regulated with the steroidogenesis by adrenocor-
ticotropic hormone, human chorionic gonadotropin, and estro-
gen (17, 19). Furthermore, SR-BI expression in adrenals is
up-regulated in apoA-I knockout mice, hepatic lipase knockout
mice, and lecithin:cholesterol acyltransferase knockout mice
(18, 20). Unlike the steroidogenic tissues, SR-BI expression in
the liver is down-regulated by estrogen treatment of rats (17).
We showed recently that the down-regulation of SR-BI expres-
sion in the liver is limited to the parenchymal cells and is
correlated with a decrease in the selective HDL-CE uptake
(21). Surprisingly, SR-BI expression and the selective HDL-CE
uptake is up-regulated in Kupffer cells after 17-a-ethinyl es-
tradiol (EE) treatment or a high cholesterol diet, pointing to a
different regulatory response in tissue macrophages (Kupffer
cells) as compared with parenchymal cells (21).
Our present goal was to analyze whether SR-BI may mediate
the increased hepatic uptake of oxidized cholesterol esters in
vitro and in vivo. We investigated the potential role of scav-
enger receptor BI in the efficient removal of HDL-CEOH by rat
liver cells by performing in vitro competition studies with li-
gands specific for scavenger receptor BI. In vivo, the effect of
the regulation of SR-BI in liver cells by EE treatment or a high
cholesterol diet on the selective uptake in vivo of oxidized
cholesterol esters was studied. Finally, the uptake of both
native and oxidized HDL cholesterol esters was determined in
SR-BI-transfected CHO cells. These experiments indicate that
SR-BI can mediate the highly efficient selective uptake of oxi-
dized cholesterol esters from HDL.
EXPERIMENTAL PROCEDURES
Materials—[Cholesteryl-1,2,6,7-3H(N)]-linoleate was purchased from
NEN Life Science Products. [1a,2a(n)-3H]Cholesteryl linoleate
([3H]CH18:2) and 125I (carrier free) in NaOH were obtained from Am-
ersham Pharmacia Biotech. 2,29-Azobis-(2,4-dimethyl-valeronitrile)
was purchased from Polyscience (Warrington, Florida). 22-(N-(7-nitro-
benz-2-oxa-1,3-diazol-4-yl)amino)(NBD)-23,24-bisnor-5-cholen-3b-yl li-
noleate and carboxyfluorescein diacetate was obtained from Molecular
Probes (Eugene, OR). Egg yolk phosphatidylcholine was obtained from
Fluka (Buchs, Switzerland) the phospholipid, cholesterol oxidase-per-
oxidase aminophenazone, and glycerolphosphate oxidase-peroxidase
aminophenazone kits from Boehringer Mannheim. Ethylmercurithiosa-
licylate (thimerosal), bovine serum albumin (BSA) (fraction V), and
collagenase type I and type IV were from Sigma. Dulbecco’s modified
Eagle’s medium (DMEM) was from Life Technologies, Inc. All other
chemicals were of analytical grade.
Label Preparation—[3H]Cholesteryl-linoleate-hydroperoxide ([3H]
Ch18:2-OOH) was prepared by peroxidation of (cholesteryl-1,2,6,7-
3H(N))-linoleate with a lipid-soluble peroxyl radical generator 2,29-
azobis-(2,4-dimethyl-valeronitrile). 200 mCi of [3H]Ch18:2 in toluene
(final volume, 1 ml) was peroxidized with 2,29-azobis-(2,4-dimethyl-
valeronitrile) (0.4 M at 37 °C for 5 h). The incubation mixture was dried
under nitrogen and purified by reversed phase HPLC on an LC-18
column as described in Ref. 22. The fraction eluting between 8 and 9
min (corresponding to the retention time of an unlabeled Ch18:2-OOH
standard) was collected and dried in a SpeedVac (Savant, Bierbeek,
Belgium). The resulting [3H]Ch18:2-OOH was then chemically reduced
to the corresponding [3H]Ch18:2-OH by NaBH4 (10 mg) reduction in
methanol (1 ml) on ice (1 h) as described by Van Kuijk et al. (23).
[3H]Ch18:2-OH was extracted into hexane and purified in a second
HPLC step (LC-18 column, mobile phase acetonitrile/isopropanol/H2O,
22:27:1, v/v) (24). Fluorescent NBD-cholesteryl linoleate was oxidized
with 70% tert-butyl OOH and 100 mM Fe(II)SO4 over night at 45 °C.
This method yielded a 100% oxidation of the fluorescent cholesterol
ester as checked by TLC.
Isolation and Labeling of HDL—Human HDL was isolated from the
blood of healthy volunteers by differential ultracentrifugation as de-
scribed by Redgrave et al. (25). HDL (1.063, d , 1.21) was dialyzed
against phosphate-buffered saline/1 mM EDTA and labeled with either
[3H]Ch18:2 or [3H]Ch18:2-OH by exchange from donor particles as
reported previously (1).
HDL was labeled by incubating HDL with donor particles (mass ratio
of HDL protein:particle phospholipid, 8:1) in the presence of human
lipoprotein-deficient serum as cholesteryl ester transfer protein source
(1:1 v/v) for 8 h at 37 °C in a shaking water bath under argon as
described (2, 16). Subsequently, the labeled HDL was dialyzed against
phosphate-buffered saline/1 mM EDTA and passed through a heparin-
Sepharose affinity column to remove apoE-containing particles (26).
After the labeling procedure, the radiolabeled HDL was checked for
hydrolysis of the cholesteryl ester labels by a Bligh and Dyer extraction
(27) followed by thin layer chromatography. The effect of the labeling
procedure on HDL was analyzed by measurement of phospholipid,
cholesterol, cholesteryl ester, and triglyceride content (with the phos-
pholipid, cholesterol oxidase-peroxidase aminophenazone, and glycer-
olphosphate oxidase-peroxidase aminophenazone kits, respectively).
The density, electrophoretic a-mobility, and particle size (photon corre-
lation spectroscopy, System 4700 C, Malvern Instruments) were also
analyzed. Labeled HDL was only used when there was no change
observed in the measured composition or physical characteristics as
compared with the original unlabeled HDL batch. Additionally, to ex-
clude the possibility that endogenous HDL lipids or tracers were oxi-
dized during the labeling procedure, HPLC analyses of lipid extracts
obtained from [3H]Ch18:2-labeled HDL were performed. HDL lipids
were extracted into methanol/hexane (1:5), and the hexane phase, con-
taining the neutral lipids, was dried and analyzed by HPLC as de-
scribed (2). HDL was iodinated by the ICl method of McFarlane (28) as
modified by Bilheimer et al. (29).
Before use, LDL was dialyzed against phosphate-buffered saline
with 10 mM EDTA. Acetylation of LDL was performed by acetic anhy-
dride as described (30). LDL was oxidized by exposure to CuSO4 as
described in detail earlier (31).
Phospholipid Liposome Preparation—Unilamelar liposomes were ob-
tained by sonication of egg yolk phosphatidylcholine/phosphatidyl-
serine/cholesterol in a molar ratio of 1:1:1 as described previously (16).
Liver Association and Tissue Distribution—Male Wistar WU rats
(200–250 g) were anesthetized by intraperitoneal injection of 20 mg of
Nembutal. Body temperature was maintained with a heating lamp.
After opening of the abdomen, radiolabeled HDL was injected into the
inferior vena cava. At the indicated time point, blood sampling and
adrenal and liver excision were performed as described previously (2).
Hepatic Cellular Distribution—The hepatic cellular distribution of
HDL was studied by using a low temperature cell isolation technique as
described (32). By means of centrifugal elutriation, the Kupffer cells
were purified from the non-parenchymal cell preparation (33). The
purity of each cell fraction was checked by light microscopy after stain-
ing for peroxidase activity. Cellular cholesterol concentrations were
measured with a commercial kit as mentioned above after a Bligh and
Dyer extraction (27) of the cellular lipids.
In Vitro Studies with Freshly Isolated Rat Liver Cells—Liver cells
were isolated by perfusion of the livers of male Wistar WU rats (200–
250 g) with collagenase at 37 °C as described (33). By means of centrif-
ugal elutriation, the Kupffer cells were purified from the non-parenchy-
mal cell preparation (33). The viability (.95%) of the obtained
parenchymal cells was checked by trypan blue exclusion. The cells from
the last centrifugation step were resuspended in oxygenated DMEM
supplemented with 2% BSA, pH 7.4. For in vitro competition studies,
the liver cells were incubated with the indicated amount of radiolabeled
HDL and competitors for 180 min in 1 ml of DMEM containing 2% BSA
at 37 °C. The temperature dependence studies were performed at the
indicated temperatures for 15 min. All cell incubations were performed
in a circulating laboratory shaker (Adolf Ku¨hner AG, Basel, Switzer-
land) at 150 rpm. Every hour, the incubations were briefly oxygenated.
The viability of the cells remained higher than 88% during these long
term incubations (33). After incubation, the cells were centrifuged for 2
min at 50 3 g for parenchymal cells and 500 3 g for Kupffer cells in an
Eppendorf centrifuge and washed two times in 50 mM Tris-HCl, 0.15 M
NaCl, 0.2% BSA, pH 7.4 at 4 °C. Subsequently, the cell pellet was
washed in a similar medium without BSA. The cells were lysed in 0.1 N
NaOH, and the protein content and radioactivity were determined.
SR-BI Assays in Transfected CHO Cells—ldlA cells (clone 7), an LDL
receptor-deficient CHO line (provided by M. Krieger) were cultured in
Ham’s F-12 medium containing 5% (v/v) fetal bovine serum, 2 mM
glutamine, 50 units/ml penicillin, and 50 mg/ml streptomycin. Stable
transfectants expressing mouse SR-BI were prepared as described pre-
viously using the expression vector pCMV5 (37). Expressing lines were
isolated and maintained in medium containing 0.5 mg/ml G-418. Bind-
ing and uptake assays with transfected CHO cells were carried out
following the procedure of Acton et al. (12) as described previously (37).
Confocal Microscopy—Freshly isolated parenchymal cells were incu-
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bated on glass coverslips in 6-well plates (Costar, Cambridge MA) for
2 h at 4 °C in DMEM supplemented with 2% BSA and the indicated
amount of oxidized NBD cholesteryl linoleate-labeled HDL or carboxy-
fluorescein diacetate. Cells on the coverslips were transferred to a Zeiss
IM-35 inverted microscope (Oberkochen, Germany) with a 3 63, NA 1.4
planapochromatic objective that was equipped with a Bio-Rad MRC600
confocal visualization system. The microscope was fitted with a incu-
bation chamber to allow incubation of the cells at 37 °C.
Quantification of SR-BI Expression—The expression levels of SR-BI
in membranes of isolated parenchymal and Kupffer cells were meas-
ured on Western blot as described (21).
Protein Determination—Protein was determined according to Lowry
et al. (34) with BSA as standard.
RESULTS
Inhibition of Selective Uptake of HDL-CEOH by Rat Liver
Parenchymal Cells by Substrates of Scavenger Receptor BI—We
showed earlier that the selective uptake of HDL-CE by paren-
chymal cells could almost be completely inhibited by OxLDL
and liposomes containing phosphatidylserine, e.g. known sub-
strates for SR-BI (16). As for native cholesterol esters, the
increased selective uptake of HDL-CEOH by the liver is medi-
ated by the parenchymal cells in vivo (2). To answer the ques-
tion of whether SR-BI is mediating this increased selective
uptake of HDL-CEOH, the inhibitory effects of known SR-BI
substrates on HDL-CEOH uptake by isolated parenchymal
cells were compared with the inhibitory effects on the selective
uptake of HDL-CE and HDL particle association as measured
by iodinated HDL. Freshly isolated rat liver parenchymal cells
were incubated for 3 h at 37 °C with HDL, either iodinated or
labeled with [3H]CE or [3H]CEOH. At this time point, the
apparent association as calculated according to Pitmann (5) of
[3H]CE-labeled HDL (202 6 14 ng of HDL/mg of cell protein)
exceeded 125I-HDL (36 6 3 ng of HDL/mg of cell protein)
association by 5.6 times, whereas the association of [3H]CEOH-
HDL (966 6 150 ng of HDL/mg of cell protein) apparently
exceeded 125I-HDL association by 27 times. The ability of (mod-
ified) lipoproteins to compete for [125I]HDL and selective
HDL-CE and HDL-CEOH uptake was tested by co-incubation
with either 100 mg/ml LDL, acetylated LDL, or OxLDL and
either neutral liposomes or liposomes containing phosphatidyl-
serine (Fig. 1). Addition of either 100 mg/ml LDL or modified
LDL only marginally (,10%) decreased the cell association of
[125I]HDL. [3H]CE-HDL and [3H]CEOH-HDL association was
also not significantly affected by addition of LDL. However,
addition of acetylated LDL led to a 35 and 30% inhibition of
[3H]CE-HDL and [3H]CEOH-HDL association, respectively,
whereas OxLDL decreased their uptake by 75 6 2.4 and 75 6
5.4%, respectively. Liposomes consisting of phosphatidylcho-
line, cholesterol, and the anionic phospholipid phosphatidyl-
serine inhibited both HDL-CE and HDL-CEOH uptake by almost
50% (Fig. 1), whereas [125I]HDL association was increased. Neutral
liposomes, consisting only of phosphatidylcholine and cholesterol,
did not influence HDL-CE and HDL-CEOH uptake. The possibility
of exchange of [3H]CE and [3H]CEOH to the other lipoproteins and
liposomes was tested by isolating the lipoproteins after incubation
for 3 h at 37 °C. Both gradient density ultracentrifugation and
agarose gel electrophoresis were performed. Less than 5% of both
[3H]CE and [3H]CEOH was recovered in the LDL, acetylated LDL,
OxLDL, or liposomal fraction after incubation for 3 h at 37 °C,
establishing that exchange to competitors could not explain the
achieved results. Therefore, both OxLDL and the phosphatidyl-
serine liposomes were effective inhibitors of HDL-CEOH uptake by
the liver parenchymal cells, and the inhibition of HDL-CEOH up-
take was comparable to the inhibition of HDL-CE uptake. The
effective inhibition of the selective uptake of oxidized cholesterol
esters, like that of native cholesterol esters from HDL, did not
correlate with a similar inhibition of the HDL particle association
(16). Apparently, the total amount of HDL binding sites in liver
exceeds the amount of SR-BI-mediated binding sites, albeit these
latter are efficiently coupled to selective uptake. This is in agree-
ment with the limited amount of poly I-insensitive binding sites for
OxLDL on parenchymal cells (31) as compared the total amount of
HDL binding sites (less than 10%).
The inhibitory effect of OxLDL on the the selective uptake of
HDL-CEOH was further analyzed with respect to efficiency of
competition. Increasing concentrations of OxLDL were added
to freshly isolated parenchymal cells in the presence of
[3H]CEOH-labeled HDL. Already at 20 mg/ml OxLDL, the up-
take of HDL-CEOH was inhibited by more than 70% (Fig. 2).
Poly I, an established inhibitor of scavenger receptor class A,
did not lower the cell association of [3H]CEOH-HDL. The si-
multaneous presence of increasing concentrations of OxLDL
and 100 mg/ml poly I did not influence the inhibitory action of
OxLDL, indicating that the effect of OxLDL was not due to
interaction with a poly I-sensitive site.
The selective uptake of HDL-CEOH was also analyzed by
confocal laser scanning microscopy using HDL labeled with a
fluorescent analog of CEOH. The uptake of fluorescent NBD-
CEOH was followed by up to 3 h of incubation with parenchy-
mal cells. During the incubation period, some parenchymal cell
pairs, which were not separated during the isolation procedure,
regained their cellular polarity and formed active bile canalic-
uli. These so-called parenchymal cell couplets (35) allow to
FIG. 1. Effect of native and modified
lipoproteins and neutral and phos-
phatidylserine liposomes on the pa-
renchymal cell association of 125I-
HDL, [3H]CE-, or [3H]CEOH-labeled
HDL. Rat liver parenchymal cells were
incubated for 3 h at 37 °C with 10 mg/ml
labeled HDL in the absence or presence of
100 mg/ml unlabeled competitors in
DMEM with 2% BSA. The 100% value for
association of [3H]CE- or [3H]CEOH-la-
beled HDL was 202 6 14 and 966 6 150
ng of HDL/mg of cell protein, respectively,
and for 125I-HDL association, it was 36 6
3 ng of HDL/mg of cell protein. The asso-
ciation is expressed as the percentage of
the radioactivity obtained in the absence
of competitor. The results are given as
means 6 S.E. (n 5 3).
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follow bile-directed transport of fluorescent cholesterol esters.
At 3 h of incubation at 37 °C, most of the label inside the cell
was concentrated in the bile canalicular vacuole of the paren-
chymal cell couplets, indicating a very efficient biliary secretion
of oxidized cholesterol esters (Fig. 3). A very punctuate labeling
in the cells was also observed. Addition of 100 mg/ml OxLDL
abolished uptake of fluorescent CEOH almost completely.
As a control, carboxyfluorescein diacetate was used, which is
a substrate for an ATP-dependent organic anion transporter of
the bile canalicular membrane and which is absent in TR2 rats
(42, 43). A concentration of fluorescence in the bile canalicular
vacuole similar to that of the oxidized cholesterol esters was
noticed.
Uptake of HDL-CEOH by the Liver and Adrenals in Vivo—
The main uptake site of [3H]CEOH-labeled HDL in vivo is the
liver (2). The liver uptake of [3H]CEOH-HDL 30 min after
injection was 27.0 6 1.9 injected dose% (Fig. 4) and was 2.3-fold
higher than the liver uptake of native HDL-CE (n 5 4). When
the adrenal uptake of [3H]CEOH-HDL was compared with the
uptake of [3H]CE-HDL, a similar 2.6-fold difference in uptake
was seen. Adrenal uptake at 30 min after injection was 2.0 6
0.7 injected dose% and 5.1 6 0.6% for [3H]CE-HDL and
[3H]CEOH-HDL, respectively (n 5 4). No other organs have a
preferential uptake of HDL-CEOH as compared with native
HDL-CE (2).
Intrahepatic Cellular Uptake in Vivo of HDL-CEOH: Effect of
17a-Ethinyl Estradiol Treatment or a High Cholesterol Diet on
SR-BI Expression and HDL-CEOH Uptake—Treatment of rats
with EE for 5 consecutive days or a high cholesterol diet for 2
weeks lowered expression of SR-BI in the liver parenchymal
cells, whereas the expression of SR-BI in the Kupffer cells was
increased as previously reported (Table I) (21). Furthermore, it
was found that the induced changes in hepatic SR-BI expres-
sion were well correlated to changes in the selective uptake of
HDL-CE (21). In order to test whether the changes in SR-BI
expression induced by either EE treatment or a high choles-
terol diet also affected the increased selective uptake of HDL
CEOH, the liver uptake of [3H]CEOH-labeled HDL was deter-
mined, as well as the association of iodinated HDL in order to
analyze total particle association. To identify the changes in
the cellular uptake sites for [3H]CEOH-HDL, parenchymal
cells and the liver tissue macrophages (Kupffer cells) were
isolated (Fig. 5). Treatment of rats with EE for 5 days resulted
in a significant 50% decrease in [3H]CEOH-HDL uptake by the
liver, whereas uptake of 125I-labeled HDL was not significantly
changed (data not shown). Thus, the selective uptake of HDL-
CEOH was greatly inhibited by treatment of rats with EE, in
accordance with the supposed role of SR-BI as the mediator of
selective HDL-CEOH uptake. This decrease in selective uptake
of HDL-CEOH by the liver can be explained by a 64% decrease
in [3H]CEOH-HDL uptake by the parenchymal cells after EE
treatment. In contrast, the Kupffer cells showed a significant
FIG. 2. Effect of increasing concentrations of OxLDL and poly
I on the parenchymal cell association of [3H]CEOH-labeled
HDL. Rat liver parenchymal cells were incubated for 3 h at 37 °C with
10 mg/ml labeled HDL in the presence of the indicated amounts of
OxLDL (l—l) or poly I (E—E). When OxLDL was added together with
poly I (e—e), a fixed 100 mg/ml of poly I was applied. The association
is expressed as the percentage of the radioactivity obtained in the
absence of competitor. The results are given as means 6 S.E. (n 5 3).
FIG. 3. Visualization of the interaction of oxidized NBD cho-
lesteryl linoleate-labeled HDL with liver parenchymal cell cou-
plets and the effect of OxLDL. Freshly isolated parenchymal cells
were preincubated on glass coverslips for 2 h at 4 °C in DMEM supple-
mented with 2% BSA and 50 mg/ml HDL labeled with oxidized NBD
cholesteryl linoleate in the presence (B) or absence (A) of 100 mg/ml
OxLDL. Cells were analyzed with a confocal microscope fitted with a
incubation chamber to allow incubation of the cells at 37 °C. The fluo-
rescence of oxidized NBD cholesteryl linoleate is the result of a 3-h
incubation of the cells at 37 °C. As a control, 5 mg/ml carboxyfluorescein
diacetate, a substrate for an ATP-dependent organic anion transporter
of the bile canalicular membrane, was used and incubated for 3 h at
37 °C with the cells (C).
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6.6-fold increase (p , 0.05) in uptake of [3H]CEOH-HDL.
Rats were also fed a high cholesterol containing diet for 2
weeks. This diet increased the plasma cholesterol levels 20-fold
as compared with the control animals, as described previously
(21), whereas total cholesterol concentration in the liver in-
creased more than 10-fold. The total cellular cholesterol con-
centration in parenchymal cells increased from the control
value of 11 6 0.9 ng/mg of cell protein up to 136 6 18 ng/mg of
cell protein (n 5 3) (mean 6 S.E.), whereas the cholesterol
content in the Kupffer cells increased from 6.8 6 0.2 ng/mg of
cell protein in the control animals up to 155 6 66 ng/mg of cell
protein after the 2-week diet (n 5 3). This diet resulted in a
very significant (p , 0.01) 80% decrease in selective uptake of
[3H]CEOH-HDL by the liver (Fig. 5). The 2-week high choles-
terol diet inhibited only the parenchymal cell uptake of
[3H]CEOH-HDL (81%), whereas Kupffer cell uptake of
[3H]CEOH-HDL was almost 5-fold increased. The decrease in
HDL-CEOH uptake by the parenchymal cells and increase in
HDL-CEOH uptake by the Kupffer cells after either EE treat-
ment or high cholesterol diet is similar, as was found with
native HDL-CE, and correlates with the induced changes in
hepatic SR-BI expression (21).
The effects of EE treatment or a high cholesterol diet on the
selective uptake of HDL-CEOH was also studied in vitro. He-
patic parenchymal cells were isolated from both EE-treated
rats and rats that had been fed a high cholesterol diet for 2
weeks. The concentration dependence of the cell association of
[3H]CEOH-HDL was studied (Fig. 6). Data are expressed in
terms of apparent particle uptake as originally devised by
Pittman et al. (5). Parenchymal cells isolated from both EE-
treated rats and from rats fed on a high cholesterol diet showed
a significant decrease in [3H]CEOH-HDL association (p , 0.05,
two-way analysis of variance) in vitro (Fig. 6). These in vitro
data thus illustrate that the changes in in vivo uptake are also
reflected in vitro with the isolated parenchymal cells.
SR-BI Transfection Studies—To assess the ability of SR-BI
to mediate the uptake of oxidized cholesterol esters from HDL,
stable CHO cell transfectants expressing mouse SR-BI were
used for cell association studies. SR-BI-specific values were
determined as the difference between the values for the SR-BI-
transfected cells and the control ldlA cells. CHO cells express-
ing SR-BI showed a clear selective uptake of both native and
oxidized cholesterol esters (Fig. 7) wherein the apparent asso-
ciation of [3H]CE-HDL and [3H]CEOH-HDL exceeded the 125I-
HDL association 7.8 and 20 times, respectively (30-min incu-
bation). The rate of uptake of [3H]CEOH-HDL by transfected
cells was markedly greater (3.4 6 0.6 (n 5 3) at 30 min of
incubation) than that of native HDL cholesterol esters. The
amount of cell-associated [125I] HDL was also increased in
SR-BI-transfected cells as compared with mock-transfected
cells, but it did not differ significantly between CEOH-HDL
and CE-HDL (Fig. 7, C and D).
DISCUSSION
The generally accepted anti-atherogenic effect of HDL can be
based upon several mechanisms. The protective role of HDL is
classically associated with reverse cholesterol transport, as
first proposed by Glomset (3). In addition to this generally
accepted concept, HDL may also protect against oxidation of
LDL (7), thereby preventing the formation of an atherogenic
form of LDL. The mechanism by which HDL exerts its antiox-
idant action is still speculative. It was suggested that the
degree of protection during LDL oxidation was directly related
to the paraoxonase activity of HDL (36). In addition, Kunitake
FIG. 4. Tissue distribution of [3H]CEOH-HDL and [3H]CE-HDL
at 30 min after injection in the rat. 300–400 mg (500000 dpm) of
[3H]CEOH-HDL or [3H]CE-HDL was injected into the inferior vena
cava of anaesthetized rats. 30 min after injection, the amount of radio-
activity was determined after combustion in a Hewlett-Packard sample
oxidizer 306 and counting for radioactivity. The total recovery of label
was 94 and 86% of the injected dose for [3H]CEOH and [3H]CE-HDL,
respectively. Values are means 6 S.E. of four experiments. ** indicates
extremely significant difference (p ,0.005). * indicates significant dif-
ference (p , 0.05) (unpaired Student’s t test).
TABLE I
SR-BI expression levels on parenchymal and Kupffer cell membranes
Cell membranes from parenchymal (PC) and Kupffer (KC) cells were
isolated from control rats, rats treated with EE (5 mg/kg) for 5 days, or
rats that had been fed a high-cholesterol diet for 2 weeks. Solubilized
membrane proteins were subjected to SDS-polyacrylamide gel electro-
phoresis and blotted on to nitrocellulose membranes. SR-BI was visu-
alized by immunolabeling followed by enhanced chemiluminescence
detection and quantitated (21). Values are means 6 S.E. of three
experiments.
Control EE Cholesterol diet
% of control
PC 100 6 4.5 15.5 6 4.1a 25.0 6 6.0a
KC 100 6 5.0 388 6 55.0a 310 6 75.0b
a Indicates very significant difference, p , 0.005.
b Significant difference, p 5 0.05 (unpaired Student’s t test).
FIG. 5. In vivo distribution of [3H]CEOH-HDL between paren-
chymal and Kupffer cells at 10 min after injection in EE-treated
rats, rats fed with a high cholesterol diet, or control rats. Shown
are the results for control rats (open bars) and rats treated with EE (5
mg/kg) for 5 days (hatched bars) or put on a high cholesterol diet for 2
weeks (black bars). At 10 min after injection of [3H]CEOH-HDL, the
liver was perfused, and parenchymal cells (PC) and Kupffer cells (KC)
were isolated at 4 °C. Values, expressed as the percentage of the in-
jected dose 3 103/mg of cell protein, are means 6 S.E. of five experi-
ments. ** indicates very significant difference (p , 0.01). * indicates
significant difference (p , 0.05) (unpaired Student’s t test).
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et al. (38) showed that HDL-associated cearuloplasmin or
transferrin could scavenge metal ions and thus prevent catal-
ysis of lipid peroxidation in LDL. However, in the same studies,
ultracentrifugally prepared HDL, which looses most of its as-
sociated enzymes, still retained antioxidant activity. In addi-
tion, reconstituted HDL, not containing any undefined pro-
teins, decreased the capacity of OxLDL to form foam cells (39).
Parthasarathy et al. (40) suggested that HDL may act as a
reservoir for lipid peroxides. HDL is suggested to break the
chain of lipid peroxide propagation by taking over LDL lipid
peroxides. Consistent with this theory, it was found that HDL
is the major carrier of lipid hydroperoxides in human blood.
More than 85% of all detectable oxidized lipids in human
plasma are associated with HDL, whereas LDL is relatively
peroxide-free (10). HDL-associated lipid hydroperoxides are
readily reduced by an intrinsic peroxidase activity leading to
less reactive hydroxides (9), an activity that may be exerted by
apoA-I and apoA-II (41).
The biological fate of HDL-associated oxidized cholesterol
esters was until recently unexplored. Sattler and Stocker (8)
showed that oxidized cholesterol esters in HDL are taken up to
a greater extent by HepG2 cells in vitro than native cholesterol
esters. Recently, we showed that oxidized cholesterol esters
show an increased serum decay as compared with native cho-
lesterol esters, whereas the liver uptake exceeded particle up-
take, thus indicating selective delivery (2). The selective up-
take of HDL-CEOH by the liver is 8.2-fold higher than native
cholesterol ester uptake at 2 min after injection, whereas after
30 min, the uptake is still 2.3-fold higher. This process is,
within the liver, selectively exerted by the parenchymal cells,
and it is coupled to efficient biliary excretion. However, the
mechanism of the highly efficient uptake of HDL-CEOH was
not clear.
The liver and steroid-forming tissues are mainly responsible
for the clearance of native HDL cholesteryl esters from the
blood circulation (1, 5, 6), and SR-BI is now held responsible for
mediating the selective uptake of native HDL-CE by these
organs (12, 17, 18). The presence of hydroxyl groups in oxidized
cholesterol esters yields a better solubility in water, enabling
the cholesteryl hydroxides to transfer more efficiently through
an aqueous phase between HDL and cellular membranes. This
might explain the increased cellular uptake of HDL-CEOH.
However, based upon our previous in vivo experiments (2), it
was concluded that this increased solubility did not lead to an
increased uptake by all cell types but, within the liver, appar-
ently only by the parenchymal cells. In addition, the adrenals,
which are known to have a high expression of SR-BI, show a
similar increased uptake of HDL-CEOH as compared with
native HDL-CE. Apparently, a cell-specific process is mediat-
ing uptake of oxidized cholesterol esters in vivo, similar to the
uptake of native cholesterol esters. We now suggest that indeed
FIG. 6. Concentration dependence of [3H]CEOH-HDL associa-
tion to rat liver parenchymal cells isolated from control rats,
EE-treated rats, or cholesterol-fed rats. Rat liver parenchymal cells
were isolated from control rats, rats treated with EE (5 mg/kg) for 5
days, or rats on a high cholesterol diet for 2 weeks. Rat liver parenchy-
mal cells were incubated for 3 h at 37 °C with the indicated amount of
labeled HDL in DMEM with 2% BSA (w/v). Data are expressed in terms
of apparent particle uptake. The values are corrected for nonspecific cell
association in the presence of a 20-fold excess of HDL (n 5 2 separate
cell isolations).
FIG. 7. Time dependence of the selec-
tive uptake of [3H]CE and [3H]CEOH-
HDL by SR-BI-transfected CHO cells.
Cells were incubated at 37 °C with labeled
HDL (10 mg of protein/ml) for the indicated
times, and cell-associated label was quanti-
fied as described under “Experimental Pro-
cedures.” A and B, cells were incubated with
[3H]CE-HDL (A) or [3H]CEOH-HDL (B). C
and D, cells were incubated with 125I-labeled
CE HDL (C) or 125I-labeled CEOH-HDL (D).
Values represent the mean of duplicate de-
terminations. Similar results were obtained
in two additional experiments.
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the increased selective uptake of oxidized cholesterol esters as
compared with native cholesterol esters is mediated by SR-BI.
We obtained five points of evidence for this involvement. First,
the increased selective uptake of HDL-CEOH by isolated pa-
renchymal cells can be blocked by oxidized LDL, acetylated
LDL, and phosphatidylserine liposomes to an extent similar to
native cholesterol ester uptake. Second, the effect of oxidized
LDL is not influenced by the simultaneous presence of poly I,
indicating a poly I-insensitive site for OxLDL interaction.
Third, in vivo the increased uptake of oxidized versus native
cholesterol esters in untreated rats is only exerted by the
parenchymal cells of the liver and by the adrenals, the cellular
sites where SR-BI is expressed. Fourth, within the liver, the
uptake of oxidized cholesterol esters and native cholesterol
esters are regulated to a similar extent by estradiol treatment
and by a high cholesterol diet, whereby the in vivo uptake by
parenchymal cells is decreased and the uptake by Kupffer cells
is increased. These latter changes parallel the expression of
SR-BI as analyzed on Western blots. Fifth, the SR-BI-trans-
fected CHO cells show a very efficient selective uptake of oxi-
dized cholesterol esters, exceeding particle association by 20
times at 30 min of incubation, while oxidized cholesterol ester
uptake at this time point is 3.4 times higher than for native
cholesterol esters.
Recently, Thuren et al. (44) observed that an antibody
against SR-BI does block the selective uptake of native choles-
terol esters by isolated parenchymal cells by up to 75%, con-
firming our initial findings that substrates for SR-BI inhibit
the selective uptake of HDL cholesterol esters (16) in these cell
types. Furthermore, the similarity in uptake behavior observed
in this study between native and oxidized cholesterol esters by
rat parenchymal cells, together with the antibody data, are in
accordance with our suggestion for SR-BI involvement for both
native and oxidized cholesterol esters from HDL.
Oxidized lipids might be recognized by types of scavenger
receptors other than SR-BI, and we have shown earlier that
oxidized LDL is rapidly removed from the blood circulation by
Kupffer cells (31). In untreated rats, we did not observe any
selective uptake of CE-OH by the Kupffer cells; thus, the Ox-
LDL-specific recognition site of Kupffer cells (probably macro-
sialin (45)) does not interact with the oxidized cholesterol es-
ters from HDL. Down-regulation of SR-BI by estradiol or a high
cholesterol diet leads to a 64 or 81% inhibition, respectively, of
the oxidized cholesterol ester uptake by parenchymal cells. It
thus appears that SR-BI is a major determinant for the selec-
tive uptake of oxidized cholesterol esters, leaving only a low
percentage of contribution for other receptors.
The mechanism for the more effective cellular uptake of
oxidized cholesterol esters as compared with native cholesterol
esters from HDL by SR-BI is presently unclear. The higher
solubility of oxidized cholesterol esters as compared with native
cholesterol esters might either facilitate the interaction of
CEOH from HDL with the active site of SR-BI or facilitate its
further transport into the cell. Whatever its mechanism, it
might be concluded that the association of enzymatic activities
with HDL together with the efficient clearance route of HDL-
associated oxidized cholesterol esters as exerted by SR-BI on
liver parenchymal cells may work synergistically to detoxify
lipid hydroperoxides and thereby protect LDL from oxidation
in vivo. This scavenging function of SR-BI for oxidized lipids is
in line with the expected function of a member of the scavenger
receptor family.
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